This inventor holds 1 USPTO granted patent. Top assignee: Institut Gustave Roussy. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Stéphanie Buart: Innovator in Cancer Treatment Assessment
Introduction
Stéphanie Buart is a notable inventor based in Villejuif, France. He has made significant contributions to the field of cancer treatment through his innovative research and inventions. His work focuses on improving the assessment of responses to targeted therapies, particularly in the context of immunotherapy.
Latest Patents
Stéphanie Buart holds a patent for a method that assesses the response to PD-1/PDL-1 targeting drugs. This invention is based on the differential expression levels of BINP3 and GBE1. His patent represents a crucial advancement in understanding how patients respond to these therapies, which are vital in the treatment of various cancers. He has 1 patent to his name.
Career Highlights
Stéphanie Buart is affiliated with the Institut Gustave Roussy, a leading cancer research institution. His work there has positioned him at the forefront of cancer research and treatment innovation. His dedication to improving patient outcomes through scientific research is commendable.
Collaborations
Stéphanie collaborates with Salem Chouaib, a fellow researcher in the field. Their partnership enhances the research efforts at the Institut Gustave Roussy, contributing to the advancement of cancer treatment methodologies.
Conclusion
Stéphanie Buart's contributions to cancer treatment assessment through his innovative patent highlight his role as a key figure in medical research. His work continues to pave the way for improved therapeutic strategies in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile